HomeESPR • NASDAQ
add
Esperion Therapeutics Inc
Nakaraang pagsara
$2.72
Sakop ng taon
$0.69 - $3.94
Market cap
631.45M USD
Average na Volume
8.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 82.38M | 11.58% |
Gastos sa pagpapatakbo | 39.51M | -10.58% |
Net na kita | -12.72M | 79.45% |
Net profit margin | -15.45 | 81.58% |
Kita sa bawat share | -0.02 | 56.55% |
EBITDA | 7.12M | 175.62% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 86.06M | -54.54% |
Kabuuang asset | 347.08M | -1.49% |
Kabuuang sagutin | 780.59M | 12.07% |
Kabuuang equity | -433.51M | — |
Natitirang share | 201.62M | — |
Presyo para makapag-book | -1.25 | — |
Return on assets | 5.29% | — |
Return on capital | 10.67% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -12.72M | 79.45% |
Cash mula sa mga operasyon | -31.42M | -336.11% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 2.85M | 109.49% |
Net change in cash | -28.57M | 23.41% |
Malayang cash flow | -38.50M | -4,144.05% |
Tungkol
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Itinatag
May 1998
Website
Mga Empleyado
304
